HARVARD BIOSCIENCE INC
HARVARD BIOSCIENCE INC
Aktie · US4169061052 · HBIO · 578107 (XNMS)
Übersicht Finanzkennzahlen
0,40 USD
0,12 % 0,0005 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
05.06.2025 22:20

Aktuelle Kurse von HARVARD BIOSCIENCE INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
HBIO
USD
05.06.2025 22:20
0,40 USD
0,40 USD
+0,17 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,12 % -30,79 % 15,47 % -50,78 % -82,23 % -87,17 % -85,45 %

Firmenprofil zu HARVARD BIOSCIENCE INC Aktie

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

Unternehmensdaten

Name HARVARD BIOSCIENCE INC
Firma Harvard Bioscience, Inc.
Symbol HBIO
Website https://www.harvardbioscience.com
Heimatbörse XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN 578107
ISIN US4169061052
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Mr. James W. Green
Marktkapitalisierung 17 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,3 T
Adresse 84 October Hill Road, 01746 Holliston
IPO Datum 2001-03-19

Aktien-Splits

Datum Split
04.11.2013 1319:1000

Ticker Symbole

Name Symbol
Frankfurt HBI.F
NASDAQ HBIO

Weitere Aktien

Investoren die HARVARD BIOSCIENCE INC die halten, haben auch folgende Aktien im Depot:
ALIGN TECHNOLOGIESLOGY INC
ALIGN TECHNOLOGIESLOGY INC Aktie
AMGEN INC
AMGEN INC Aktie
APPLE INC
APPLE INC Aktie
AUTODESK INC
AUTODESK INC Aktie
BARING EAST.TR.ACC.(DL)
BARING EAST.TR.ACC.(DL) Fonds
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
MOMO INC - AMERICAN DEPOSITARY SHARES
MOMO INC - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
MPT OPER.PARTN. 20/31
MPT OPER.PARTN. 20/31 Anleihe
SUMITOMO CHEM.
SUMITOMO CHEM. Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025